A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less - Concepedia

Concepedia

Publication | Open Access

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

DOI Full Paper Access

2.7K

Citations

33

References

1997

Year

Scott M. Hammer, Kathleen Squires, Michael D. Hughes, Janet M. Grimes, Lisa M. Demeter, Judith S. Currier, Joseph J. Eron, Judith Feinberg, Henry H. Balfour, Lawrence Deyton,

New England Journal of Medicine

Abstract

Treatment with indinavir, zidovudine, and lamivudine as compared with zidovudine and lamivudine alone significantly slows the progression of HIV-1 disease in patients with 200 CD4 cells or fewer per cubic millimeter and prior exposure to zidovudine.

References

	Year	Citations

Page 1